Quoin Pharmaceuticals, Ltd. Quarterly Retained Earnings (Accumulated Deficit) in ILS for Q2 2021

Taxonomy & unit
us-gaap: ILS and USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Quoin Pharmaceuticals, Ltd. quarterly Retained Earnings (Accumulated Deficit) history and growth rate for Q2 2021.
  • Quoin Pharmaceuticals, Ltd. Retained Earnings (Accumulated Deficit) for the quarter ending June 30, 2021 was ₪129M.
Retained Earnings (Accumulated Deficit), Quarterly (ILS)
Period Value YoY Chg Change % Date Report Filed
Q2 2021 129M Jun 30, 2021 6-K 2021-08-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.